How Has the Biophotonics Market Size Evolved in Recent Years?
The biophotonics market has seen considerable growth due to a variety of factors.
• Rapid growth has been observed in the size of the biophotonics market in the last few years. The market is projected to expand from a worth of $83.26 billion in 2024 to an estimated value of $92.33 billion in 2025, showcasing a compound annual growth rate (CAGR) of 10.9%.
The driving factors for this growth in the historic period include advancements in medical imaging, disease diagnosis and monitoring, developments in life sciences research, the evolution of optical sensing and spectroscopy, as well as innovations in lasers and light sources.
What Is The Forecast For The Biophotonics Market Size In The Coming Years?
The biophotonics market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the biophotonics market is predicted to witness a swift expansion. The market is projected to escalate to a value of $149.06 billion in 2029, showcasing a compound annual growth rate (CAGR) of 12.7%.
Factors contributing to this growth during the forecast period include the emergence of personalized medicine, precision farming, global healthcare initiatives, the use of wearable and mobile health technology, and an emphasis on environmental monitoring and safety. Additionally, the forecast period will see significant trends such as the miniaturization and development of point-of-care devices, multimodal imaging, optogenetics, along with an increased role of machine learning and data analytics, and smart imaging probes.
What Are The Primary Growth Drivers In The Biophotonics Market?
The demand for minimally invasive surgeries is propelling the growth of the biophotonics market. Optical engineering and imaging technologies are proving vital for these procedures as they allow real-time observation of tissue manipulation within inaccessible internal areas. For example, reports from Intuitive Surgical Inc., a US firm that manufactures robotic products, stated in January 2023 that around 1,875,000 surgical operations were performed using a Vinci Surgical Systems in 2022. Interestingly, this figure represents a significant 18% rise from the about 1,594,000 surgical operations undertaken with a Vinci Surgical Systems in 2021. Therefore, the growing amount of minimally invasive surgeries performed globally every year is resulting in increased earnings for the biophotonics market.
How Is The Global Biophotonics Market Divided Into Key Segments?
The biophotonics market covered in this report is segmented –
1) By Product Technology: In-Vitro, In-Vivo
2) By Application: See-Through Imaging, Inside Imaging, Spectromolecular, Surface Imaging, Microscopy, Light Therapy, Biosensors, Other Applications
3) By End Use: Diagnostics, Therapeutic, Tests, Other End Uses
Subsegments:
1) By In-Vitro: Diagnostic Imaging, Fluorescence Microscopy, Spectroscopy-Based Detection, Biochemical Sensors, Point-Of-Care Devices
2) By In-Vivo: Endoscopy, Optical Coherence Tomography (OCT), Photodynamic Therapy (PDT), Bioluminescence Imaging, Near-Infrared Spectroscopy (NIRS)
Pre-Book The Biophotonics Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Biophotonics Market?
The introduction of innovative and sophisticated methods in biotechnology is a significant trend impacting the biophotonics market. For example, a group of researchers at the University of St. Andrews in Scotland formulated a fluorescence microscopy method that facilitates the imaging of fragile biological specimens with minimal damage in the field of neuroscience and biomedicine. It is anticipated that this minimal-damage optical technique will revolutionize the biomedicine sector in the upcoming years. Therefore, the creation and implementation of novel and advanced methods are increasingly becoming popular in the biophotonics market.
Who Are the Key Players In The Biophotonics Market?
Major companies operating in the biophotonics market include:
• Thermo Fisher Scientific Inc.
• OpGen Inc.
• NU Skin Enterprises Inc.
• IPG Photonics Corporation
• Idex Corporation
• Toshiba Corporation
• Horiba Ltd.
• Precision Photonics Corp
• Roche Group
• General Electric Company
• Koninklijke Philips NV
• Affymetrix Inc.
• Andor Technology Ltd.
• Becton Dickinson & Co
• Carl Zeiss AG
• FEI Company
• Hamamatsu Photonics KK
• Lumenis Ltd.
• Olympus Corporation
• PerkinElmer Inc.
• Zecotek Photonics Inc.
• Zenalux Biomedical Inc.
• Glenbrook Technologies Inc.
• Oxford Instruments Plc
• Lumicks BV
• Creoptix AG
• ThinkCyte Inc.
• PhotoPharmics Inc.
• Impedimed Ltd.
• Bioptics Inc.
What Are The Regional Insights Into The Biophotonics Market?
North America was the largest region in the biophotonics market in 2023. Western Europe was the second largest region in the biophotonics market. The regions covered in the biophotonics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
